STTK

Shattuck Labs, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website attucklabs.com
Employees(FY) 105
ISIN US82024L1035

Performance

-4.17%

+0.88%

-68.92%

-74.95%

-83.87%

YTD

-82.17%

Profile

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.

Advanced Technical Analysis

Technical Analysis of STTK 2024-12-20

The stock indicators reflect a predominantly bearish sentiment, with the Moving Average Score at 16 indicating strong downward pressure, while the Oscillators Score of 56 suggests a neutral stance. Overall, the Technical Score of 36 reinforces the bearish outlook, signaling caution for potential investors.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of STTK

Stock Rank

Recent News & Updates

2024-11-24 18:00
Shattuck Labs Announces Participation in Upcoming December Conferences(Globenewswire)
2024-11-14 18:12
Shattuck Labs sees cash runway into 2027(Yahoo Finance)
2024-11-13 18:00
Shattuck Labs Reports Third Quarter 2024 Financial Results and Recent Business Highlights(Globenewswire)
2024-10-23 21:35
Down -64.19% in 4 Weeks, Here's Why Shattuck Labs (STTK) Looks Ripe for a Turnaround(Yahoo Finance)
2024-10-07 21:35
After Plunging -68.96% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)(Yahoo Finance)
2024-10-01 23:32
Shattuck Labs stock craters following pipeline and job cuts(Yahoo Finance)
2024-10-01 18:57
Shattuck Labs Refocuses Strategy Amidst Restructuring and Cuts(Yahoo Finance)
2024-10-01 00:26
Shattuck Labs Shutters Cancer Program, Lays Off Around 40% Of Its Workforce, Reorganizes Pipeline(Yahoo Finance)
2024-09-30 18:30
Shattuck Labs Provides Company Update and Announces SL-325, a First-In-Class Death Receptor 3 (DR3) Antagonist Targeting the TL1A/DR3 Signaling Pathway(Globenewswire)
2024-08-01 06:20
Shattuck Labs, Inc. (STTK) Reports Q2 Loss, Tops Revenue Estimates(Yahoo Finance)
2024-08-01 04:05
Shattuck Labs Reports Second Quarter 2024 Financial Results and Recent Business Highlights(Globenewswire)
2024-07-30 05:00
Shattuck Labs Announces Participation in Upcoming BTIG Virtual Biotechnology Conference(Globenewswire)
2024-06-30 18:00
Shattuck Labs Announces Addition to Russell 2000 and Russell 3000 Indexes(Globenewswire)
2024-06-18 06:25
Yigal Nochomovitz Just Trimmed Price Target for Shattuck Labs, Inc. (NASDAQ:STTK)(Insidermonkey)
2024-06-17 22:48
Wall Street Analysts Just Trimmed Price Targets for These 10 Stocks(Insidermonkey)
2024-06-14 01:28
Shattuck (STTK) Announces Positive Interim Data on Cancer Drug(Zacks)
2024-06-13 18:00
Shattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leuke(Globenewswire)
2024-06-09 19:30
Shattuck Labs Announces Orphan Drug Designation Granted by the U.S. Food and Drug Administration (FDA) for SL-172154 for the Treatment of Acute Myeloid Leukemia (AML)(Globenewswire)
2024-06-05 19:30
Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Mye(Globenewswire)
2024-05-20 21:35
After Plunging -19.89% in 4 Weeks, Here's Why the Trend Might Reverse for Shattuck Labs (STTK)(Zacks)
2024-05-14 04:15
Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the Eu(Globenewswire)
2024-05-07 12:00
What Makes Shattuck Labs (STTK) a New Buy Stock(Zacks)
2024-05-07 09:55
Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?(Zacks)
2024-05-07 00:00
What Makes Shattuck Labs (STTK) a New Buy Stock(Zacks)
2024-05-06 21:55
Does Shattuck Labs (STTK) Have the Potential to Rally 34.17% as Wall Street Analysts Expect?(Zacks)
2024-05-04 08:01
Shattuck Labs First Quarter 2024 Earnings: Beats Expectations(Simply Wall St.)
2024-05-04 05:31
Shattuck Labs Inc (STTK) Reports First Quarter 2024 Financial Results(GuruFocus.com)
2024-05-02 09:58
STTK Stock Earnings: Shattuck Labs Beats EPS, Beats Revenue for Q1 2024(Investorplace)
2024-05-02 07:05
Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights(GlobeNewswire)
2024-05-01 20:25
Shattuck Labs, Inc. (STTK) Reports Q1 Loss, Tops Revenue Estimates(Yahoo Finance)

Page 1 of 6

previousnext

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.